Relation Therapeutics: Funding, Investors & Team (Sep 2026)
Connection Therapeutics takes part in adapting drug revelation and improvement. It use human hereditary qualities and clinical omics information and uses patient-inferred tissue tests with practical genomics interventional trials to distinguish, approve and indict remedial projects.
Relation Therapeutics has raised $126M across 4 funding rounds on record, the most recent an undisclosed round of $26.0M announced in Dec 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Relation Therapeutics Company Profile and Key Stats
Latest funding round on record: Dec 2025.
Relation Therapeutics Funding Rounds
Relation Therapeutics raised $25.0M in a Seed announced in Jun 2022.
1.6 years later, an undisclosed round of $40.3M was announced in Jan 2024.
2 months later, an undisclosed round of $35.0M was announced in Mar 2024.
1.8 years later, an undisclosed round of $26.0M was announced in Dec 2025.
Relation Therapeutics Founders and Leadership Team
Contact details for the Relation Therapeutics team: 2 of 2 have an email address on file.
Start 14-day free trial →Relation Therapeutics Funding Compared to Other Biotechnology Startups
Relation Therapeutics' latest round of $26.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Relation Therapeutics in Biotechnology and London
Companies Similar to Relation Therapeutics
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
IMU is a discovery engine mapping the immune system to advance precision medicine.
Mykor is a climate tech start-up. It decarbonizes the construction industry by manufacturing carbon-negative…
Neurovalens provides cutting-edge solutions in the realms of neuroscience, bioscience, and neurophysiology.…
Voxmind's biometric confirmation and authentication platform that provides voice based biometrics that helps…
Five is a biometric payment services company that offers thumb recognition technology for safe transactions.
Relation Therapeutics Funding FAQs
What does Relation Therapeutics do?
Connection Therapeutics takes part in adapting drug revelation and improvement. It use human hereditary qualities and clinical omics information and uses patient-inferred tissue tests with practical genomics interventional trials to distinguish, approve and indict remedial projects.
How much funding has Relation Therapeutics raised?
Relation Therapeutics has raised $126M across 4 rounds on record. The most recent is an undisclosed round of $26.0M announced in Dec 2025.
When did Relation Therapeutics last raise funding?
Relation Therapeutics' most recent funding round on record is an undisclosed round of $26.0M, announced in Dec 2025.
Who founded Relation Therapeutics?
FundedIQ lists Benjamin Swerner (Founder), Jake Taylor King (Founder) at Relation Therapeutics.
Where is Relation Therapeutics headquartered?
Relation Therapeutics is based in London, England, United Kingdom.
How many employees does Relation Therapeutics have?
Relation Therapeutics is in the 11-50 employee band.
How does Relation Therapeutics' funding compare to other Biotechnology startups?
Relation Therapeutics' latest round of $26.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Relation Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Relation Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.